ARVN FY 2022 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$907M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$131M+145.1% YoY

Gross Profit

$131M100.0% margin

Operating Income

-$263M-200.3% margin

Net Income

-$283M-215.0% margin

EPS (Diluted)

$-5.31

Cash Flow

Operating Cash Flow

-$274M

Free Cash Flow

-$280M

Stock-Based Comp.

$76M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$704M

Stockholders' Equity

$565M

Cash & Equivalents

$81M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$131M	$54M	+145.1%
Gross Profit	$131M	$54M	+145.1%
Operating Income	-$263M	-$188M	-39.7%
Net Income	-$283M	-$191M	-47.9%